416 results on '"Forni, Flavio"'
Search Results
2. Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence
3. Cholesterol‐loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice
4. Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines
5. Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer’s disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery
6. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol
7. PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity
8. Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy
9. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol
10. Supplementary Table 1 from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
11. Supplementary Figure 3 from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
12. Supplementary Figure Legend from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
13. Supplementary Methods from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
14. Supplementary Figure 2 from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
15. Supplementary Figure 1 from Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
16. Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems
17. Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport
18. Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA)
19. Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution
20. AFM and TEM characterization of siRNAs lipoplexes: A combinatory tools to predict the efficacy of complexation
21. Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws
22. PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury
23. Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders
24. Editor's Note: Nanoparticles Engineered with Rituximab and Loaded with Nutlin-3 Show Promising Therapeutic Activity in B-Leukemic Xenografts
25. Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release
26. DOTAP/UDCA vesicles: novel approach in oligonucleotide delivery
27. Intact collagen and atelocollagen sponges: Characterization and ESEM observation
28. Origin of Δ9-Tetrahydrocannabinol Impurity in Synthetic Cannabidiol
29. Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems
30. Brain-targeted polymeric nanoparticles: in vivo evidence of different routes of administration in rodents
31. Nanoparticulate drug carriers based on hybrid poly( d,l-lactide- co-glycolide)-dendron structures
32. Colloidal systems for CNS drug delivery
33. Chemico-physical investigation of tenofovir loaded polymeric nanoparticles
34. Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery?
35. Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: Preparation, characterization and comparative in vitro study with polymeric particles and liposomes
36. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood–brain barrier
37. Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington’s disease
38. Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment
39. Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications
40. Immunoliposomal systems targeting primary effusion lymphoma: in vitro study
41. Collagen-based modified membranes for tissue engineering: Influence of type and molecular weight of GAGs on cell proliferation
42. Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes
43. Peptide-derivatized biodegradable nanoparticles able to cross the blood–brain barrier
44. Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives
45. Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications
46. The interaction of biliar acids with 2-hydroxypropyl-β-cyclodextrin in solution and in the solid state
47. Chapter 2 - Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy
48. Microwave-treated gelatin microspheres as drug delivery system
49. In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form
50. PLGA-PEG-ANG-2 Nanoparticles for Blood–Brain Barrier Crossing: Proof-of-Concept Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.